USFDA completes inspection at Alkem Laboratories’ manufacturing facility in Daman

31 Aug 2019

The US Food and Drug Administration (USFDA) has completed inspection at Alkem Laboratories’ manufacturing facility located at Daman. The agency had conducted inspection from August 26, 2019 to August 30, 2019. At the end of the inspection, the company has received a Form 483 with two observations.

Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical Ingredients (APIs) and nutraceuticals, which it markets in India and International markets.

Related Alkem Laboratories Ltd. Links:

Alkem Laboratories Share Price

2684.20 0.35 (0.01%) Oct 28, 17:23
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 463.35
Dr. Reddys Lab 4949.80
Lupin 940.40
Piramal Enterprises 1282.05
Cadila Healthcare 418.45
View more..
Sensex vs Alkem Laboratories
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback